Related Experiment Video

Updated: Oct 4, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Society of Urologic Oncology Biotechnology Forum: new approaches and targets for advanced prostate cancer

A Belldegrun1, N H Bander, S P Lerner

  • 1Division of Urologic Oncology, Department of Urology, University of California School of Medicine, Los Angeles, California, USA.

The Journal of Urology
|September 8, 2001
PubMed
Abstract

Insights

Advances in molecular therapies offer new hope for prostate cancer patients. This review covers dendritic cell immunotherapy, monoclonal antibodies, and anti-apoptotic treatments, expanding options for advanced prostate carcinoma.

Area of Science:

  • Oncology
  • Biotechnology
  • Immunotherapy

Background:

  • Prostate cancer remains a significant health concern.
  • Molecular-based therapies represent a paradigm shift in cancer treatment.
  • The 2000 Society of Urologic Oncology Biotechnology Forum highlighted key advancements.

Purpose of the Study:

  • To provide an overview of novel molecular therapeutic strategies for prostate cancer.
  • To summarize key findings presented at the 2000 Society of Urologic Oncology Biotechnology Forum.
  • To critically evaluate emerging treatment modalities.

Main Methods:

  • Review of studies presented at the 2000 Society of Urologic Oncology Biotechnology Forum.
  • Expert critique of three promising new treatment strategies.
  • Analysis of treatment results and current status of specific therapies.

Main Results:

  • Dendritic cell-based immunotherapy shows promise for prostate cancer.
  • Monoclonal antibody therapy offers targeted treatment approaches.
  • Anti-apoptotic treatment strategies aim to overcome treatment resistance.

Conclusions:

  • Molecular-based therapies are expanding treatment options for advanced prostate carcinoma.
  • Phase II and III clinical trials are crucial for validating these novel approaches.
  • Patients with advanced prostate cancer benefit from a growing array of therapeutic choices.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...